Golden State Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$633 Buy
105
+6
+6% +$45 ﹤0.01% 1495
2025
Q4
$713 Sell
99
-4
-4% -$32 ﹤0.01% 1557
2025
Q3
$1.1K Hold
103
﹤0.01% 1494
2025
Q2
$997 Hold
103
﹤0.01% 1435
2025
Q1
$1.53K Buy
103
+1
+1% +$15 ﹤0.01% 1361
2024
Q4
$1.53K Buy
+102
New +$1.66K ﹤0.01% 1290

Other funds holding OGN

Golden State Wealth Management's OGN Position: Q1 2026 in Review

Golden State Wealth Management increased its Organon & Co (OGN) stake by 6.1% in Q1 2026, buying an estimated $45 and bringing the position to 105 shares worth $633. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Golden State Wealth Management first reported a position in OGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.53K in Q1 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Golden State Wealth Management held 105 shares of Organon & Co worth $633 as of Q1 2026.
  • Golden State Wealth Management bought 6 Organon & Co shares in Q1 2026, an estimated $45.
  • Organon & Co made up ﹤0.01% of Golden State Wealth Management's portfolio in Q1 2026, its #1495 holding.
  • Golden State Wealth Management first reported a position in Organon & Co in Q4 2024 and has held it in 6 quarters since.
  • Golden State Wealth Management's Organon & Co position peaked at $1.53K in Q1 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Golden State Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.